{{Rsnum
|rsid=8051542
|Gene=TOX3
|Chromosome=16
|position=52500255
|Orientation=plus
|GMAF=0.3444
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=TOX3
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 31.0 | 47.8 | 21.2
| HCB | 67.2 | 28.5 | 4.4
| JPT | 58.4 | 38.9 | 2.7
| YRI | 60.5 | 32.7 | 6.8
| ASW | 49.1 | 35.1 | 15.8
| CHB | 67.2 | 28.5 | 4.4
| CHD | 67.0 | 27.5 | 5.5
| GIH | 46.5 | 46.5 | 6.9
| LWK | 38.2 | 51.8 | 10.0
| MEX | 32.8 | 44.8 | 22.4
| MKK | 40.4 | 46.2 | 13.5
| TSI | 34.3 | 52.0 | 13.7
| HapMapRevision=28
}}

{{omim
|desc=BREAST CANCER
|id=114480
|rsnum=8051542
}}

{{PMID Auto
|PMID=20054709
|Title=Birth weight, breast cancer susceptibility loci, and breast cancer risk
}}
{{PMID Auto
|PMID=20699374
|Title=Evaluation of Breast Cancer Susceptibility Loci in Chinese Women
|OA=1
}}
{{PMID Auto
|PMID=20703937
|Title=Association between polymorphisms of trinucleotide repeat containing 9 gene and breast cancer risk: evidence from 62,005 subjects
}}

{{PMID|17997823|OA=1
}} Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases.

{{PMID|18224312|OA=1
}} Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.

{{PMID|18681954|OA=1
}} Breast cancer susceptibility loci and mammographic density.

{{PMID|18708391|OA=1
}} Breast cancer risk polymorphisms and interaction with ionizing radiation among U.S. radiologic technologists.

{{PMID|19219042|OA=1
}} Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.

{{PMID|19639606|OA=1
}} Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases.

{{PMID|20085711|OA=1
}} Leveraging genetic variability across populations for the identification of causal variants.

{{PMID|20213080}} Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population.

{{PMID|20484103|OA=1
}} Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women.

{{PMID|20585626|OA=1
}} Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium.

{{PMID Auto
|PMID=22910930
|Title=Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.
|OA=1
}}

{{PMID Auto
|PMID=22983835
|Title=The association between polymorphisms in the leptin receptor gene and risk of breast cancer: a systematic review and pooled analysis.
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}